[Long-term treatment of venous thromboembolism in patients with cancer].

Abstract

BACKGROUND The treatment with low-molecular-weight heparin (LMWH) is recommended for patients with cancer associated thrombosis (CAT) during the first 6 months; the initial therapeutic dose can be reduced to 60-75 % after one month. The therapy should be reevaluated after 6 month and subsequent therapy using LMWH or warfarin is recommended indefinitely… (More)

Topics

Cite this paper

@article{mrha2017LongtermTO, title={[Long-term treatment of venous thromboembolism in patients with cancer].}, author={Jan {\vS}mrha and Petr Kessler and Hynek Poul and Michaela Harudov{\'a}}, journal={Vnitrni lekarstvi}, year={2017}, volume={62 6}, pages={449-52} }